Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Epigenetics Insights|April 22, 2020
Ethical Issues in Research and Development of Epigenome-wide TechnologiesEline M Bunnik, Marjolein Timmers, Ineke Lle BoltMedicine, Health Care, and Philosophy|August 11, 2022
The 'false hope' argument in discussions on expanded access to investigational drugs: a critical assessmentMarjolijn Hordijk, Stefan F Vermeulen, Eline M BunnikHealth Policy (Amsterdam, Netherlands)|June 25, 2018
Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugsEline M Bunnik, Nikkie Aarts, Suzanne van de VathorstJournal of Pharmaceutical Policy and Practice|February 28, 2017
The changing landscape of expanded access to investigational drugs for patients with unmet medical needs: ethical implicationsEline M Bunnik, Nikkie Aarts, Suzanne van de VathorstPsychiatry Research|October 27, 2023
Expanded access to investigational drugs in psychiatry: A systematic reviewStefan F Vermeulen, Tobias B Polak, Eline M BunnikStem Cell Research & Therapy|July 23, 2022
Organoids: a systematic review of ethical issuesDide de Jongh, Emma K Massey, , et al.Narrative Inquiry in Bioethics|January 1, 2019
Ethical Issues in the Beauty Salon: The Development of National Ethics Guidelines for Aestheticians in the NetherlandsEline M Bunnik, Frans Meulenberg, Inez D de BeaufortNederlands Tijdschrift Voor Geneeskunde|October 12, 2023
[Prioritisation in health care: An ethical perspective]Eline M Bunnik, Jilles Smids, Charlotte H C BomhofEuropean Journal of Human Genetics : EJHG|May 29, 2024
Beyond severity: utility as a criterion for setting the scope of RGCSLisa Dive, Anne-Marie Laberge, Lucinda Freeman, et al.Bioethics|November 7, 2022
Access to effective but expensive treatments: An analysis of the solidarity argument in discussions on funding of medical treatmentsSietske A L van Till, Jilles Smids, Eline M BunnikPageof 10